These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29134256)

  • 21. Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study.
    Chow EPF; Machalek DA; Tabrizi SN; Danielewski JA; Fehler G; Bradshaw CS; Garland SM; Chen MY; Fairley CK
    Lancet Infect Dis; 2017 Jan; 17(1):68-77. PubMed ID: 27282422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human Papillomavirus neutralizing and cross-reactive antibodies induced in HIV-positive subjects after vaccination with quadrivalent and bivalent HPV vaccines.
    Faust H; Toft L; Sehr P; Müller M; Bonde J; Forslund O; Østergaard L; Tolstrup M; Dillner J
    Vaccine; 2016 Mar; 34(13):1559-1565. PubMed ID: 26896686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity and persistence of immunity of a quadrivalent Human Papillomavirus (HPV) vaccine in immunocompromised children.
    MacIntyre CR; Shaw P; Mackie FE; Boros C; Marshall H; Barnes M; Seale H; Kennedy SE; Moa A; Hayen A; Chughtai AA; O'Loughlin EV; Stormon M
    Vaccine; 2016 Aug; 34(36):4343-50. PubMed ID: 27406936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prophylactic immunization with human papillomavirus vaccines induces oral immunity in mice.
    Ahn J; Peng S; Hung CF; Roden RBS; Best SR
    Laryngoscope; 2018 Jan; 128(1):E16-E20. PubMed ID: 28868617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Second-generation prophylactic HPV vaccines: current options and future strategies for vaccines development.
    Fruscalzo A; Londero AP; Bertozzi S; Lellè RJ
    Minerva Med; 2016 Feb; 107(1):26-38. PubMed ID: 26473283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A human papillomavirus vaccine.
    Med Lett Drugs Ther; 2006 Aug 14-28; 48(1241-1242):65-6. PubMed ID: 16977280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical algorithm of cutaneous extragenital wart treatment].
    Rübben A
    Hautarzt; 2011 Jan; 62(1):6-16. PubMed ID: 21206989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A retrospective case-control analysis of the efficacy of Gardasil
    Milner TD; Harrison A; Montgomery J; MacGregor FB; Buchanan MA; MacKenzie K
    Clin Otolaryngol; 2018 Jun; 43(3):962-965. PubMed ID: 29380936
    [No Abstract]   [Full Text] [Related]  

  • 29. Characterization of serum antibodies from women immunized with Gardasil: A study of HPV-18 infection of primary human keratinocytes.
    Wang HK; Wei Q; Moldoveanu Z; Huh WK; Vu HL; Broker TR; Mestecky J; Chow LT
    Vaccine; 2016 Jun; 34(27):3171-3177. PubMed ID: 27113165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gardasil-9: A global survey of projected efficacy.
    Zhai L; Tumban E
    Antiviral Res; 2016 Jun; 130():101-9. PubMed ID: 27040313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.
    Muñoz N; Manalastas R; Pitisuttithum P; Tresukosol D; Monsonego J; Ault K; Clavel C; Luna J; Myers E; Hood S; Bautista O; Bryan J; Taddeo FJ; Esser MT; Vuocolo S; Haupt RM; Barr E; Saah A
    Lancet; 2009 Jun; 373(9679):1949-57. PubMed ID: 19493565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human Papillomavirus Infection and Vaccination.
    Valentino K; Poronsky CB
    J Pediatr Nurs; 2016; 31(2):e155-66. PubMed ID: 26586310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reductions in human papillomavirus-disease resource use and costs with quadrivalent human papillomavirus (types 6, 11, 16, and 18) recombinant vaccination: the FUTURE Study Economic Evaluation.
    Insinga RP; Dasbach EJ; Allen SE; Carides GW; Myers ER
    Value Health; 2008 Dec; 11(7):1022-32. PubMed ID: 18489503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices.
    Petrosky E; Bocchini JA; Hariri S; Chesson H; Curtis CR; Saraiya M; Unger ER; Markowitz LE;
    MMWR Morb Mortal Wkly Rep; 2015 Mar; 64(11):300-4. PubMed ID: 25811679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clearance of recalcitrant warts in a patient with idiopathic immune deficiency following administration of the quadrivalent human papillomavirus vaccine.
    Smith SP; Baxendale HE; Sterling JC
    Clin Exp Dermatol; 2017 Apr; 42(3):306-308. PubMed ID: 28070898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity and safety of quadrivalent human papillomavirus types 6/11/16/18 recombinant vaccine in chronic kidney disease stage IV, V and VD.
    Praditpornsilpa K; Kingwatanakul P; Deekajorndej T; Rianthavorn P; Susantitaphong P; Katavetin P; Tiranathanakul K; Srisawat N; Tungsanga K; Eiam-Ong S; Townamchai N
    Nephrol Dial Transplant; 2017 Jan; 32(1):132-136. PubMed ID: 26932687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain.
    Navarro-Illana E; López-Lacort M; Navarro-Illana P; Vilata JJ; Diez-Domingo J
    Vaccine; 2017 Jun; 35(25):3342-3346. PubMed ID: 28499554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gardasil 9--a broader HPV vaccine.
    Med Lett Drugs Ther; 2015 Mar; 57(1465):47-8. PubMed ID: 25853579
    [No Abstract]   [Full Text] [Related]  

  • 39. Safety and immunogenicity of the quadrivalent human papillomavirus (qHPV) vaccine in HIV-positive Spanish men who have sex with men (MSM).
    Hidalgo-Tenorio C; Ramírez-Taboada J; Gil-Anguita C; Esquivias J; Omar-Mohamed-Balgahata M; SamPedro A; Lopez-Ruz M; Pasquau J
    AIDS Res Ther; 2017 Jul; 14(1):34. PubMed ID: 28720147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.
    Goldstone SE; Vuocolo S
    Expert Rev Vaccines; 2012 Apr; 11(4):395-406. PubMed ID: 22551023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.